<DOC>
	<DOC>NCT01515202</DOC>
	<brief_summary>The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-823778 in healthy Japanese subjects and Japanese patients with Type 2 Diabetes Mellitus.</brief_summary>
	<brief_title>Japanese Phase 1 Multiple Ascending Dose Study</brief_title>
	<detailed_description>MAD study - Multiple Ascending Dose study</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Japanese patients with Type 2 Diabetes Mellitus (T2DM) [Fasting glucose &lt; 240 mg/dL, Hemoglobin A1c (HbA1c): 6.5% to 10.0% National Glycohemoglobin Standardization Program (NGSP)] who are treatmentnaive and managed with diet and/or exercises only, ages: 20 to 65 years Patient who is taking any medication for T2DM Symptoms of poorly controlled diabetes that would preclude participation in this placebocontrolled trial Insulin therapy within one year of screening</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>